Varaico: Literature-Extracted Genetic Variants

Gene:PSEN1
Variant:p.E280G
Back to variants list

PSEN1

NM_000021.4:p.E280G

Associated Papers

Novel Association of the Presenilin-1 (Leu282Arg) Mutation with Isolated Spastic Paraparesis: Case Presentation and Review of Current Evidence.

De la Sen-Domínguez M et al.

Journal of Clinical Medicine, 2025

Cytokine-induced reprogramming of human macrophages toward Alzheimer's disease-relevant molecular and cellular phenotypes in vitro.

Podleśny-Drabiniok A et al.

Cell Reports, 2025

40570367 (PubMed )
Supplement: NIHMS2099510-supplement-6.xlsx › VSQR_THP-1

The landscape of autosomal-dominant Alzheimer's disease: global distribution and age of onset.

Liu H et al.

Brain : a Journal of Neurology, 2025

39903689 (PubMed )
Supplement: awaf038_supplementary_data.zip › 2-Supplemental_Table1_AR_20250121_JLliF.pdf

Clinical Significance of Early-Onset Alzheimer's Mutations in Asian and Western Populations: A Scoping Review.

Poniah P et al.

Genes, 2025

40149496 (PubMed )
Supplement: genes-16-00345-s001.zip › genes-3411048-supplementary.pdf

The presenilin 1 mutation P436S causes familial Alzheimer's disease with elevated Aβ43 and atypical clinical manifestations.

Arber C et al.

Alzheimer's & Dementia : the Journal of the Alzheimer's Association, 2024

Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease.

Yang Y et al.

International Journal of Molecular Sciences, 2023

The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue.

Willumsen N et al.

Brain Communications, 2023

Aβ and tau prions feature in the neuropathogenesis of Down syndrome.

Condello C et al.

Proceedings of the National Academy of Sciences of the United States of America, 2022

36343257 (PubMed )
Supplement: pnas.2212954119.sapp.pdf

Genetics, Functions, and Clinical Impact of Presenilin-1 (PSEN1) Gene.

Bagaria J et al.

International Journal of Molecular Sciences, 2022

Variability in the type and layer distribution of cortical Aβ pathology in familial Alzheimer's disease.

Willumsen N et al.

Brain Pathology (zurich, Switzerland), 2022

Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.

O'Connor A et al.

Brain : a Journal of Neurology, 2021

How understudied populations have contributed to our understanding of Alzheimer's disease genetics.

Dehghani N et al.

Brain : a Journal of Neurology, 2021

Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis.

Arber C et al.

Cell Reports, 2021

Identification of a Rare PSEN1 Mutation (Thr119Ile) in Late-Onset Alzheimer's Disease With Early Presentation of Behavioral Disturbance.

Zhang S et al.

Frontiers in Psychiatry, 2020

Homozygosity for the A431E mutation in PSEN1 presenting with a relatively aggressive phenotype.

Parker J et al.

Neuroscience Letters, 2019

Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.

Weston PSJ et al.

Alzheimer's Research & Therapy, 2019

30786919 (PubMed )
Supplement: 13195_2019_472_MOESM1_ESM.docx

Young adult-onset, very slowly progressive cognitive decline with spastic paraparesis in Alzheimer's disease with cotton wool plaques due to a novel presenilin1 G417S mutation.

Miki T et al.

Acta Neuropathologica Communications, 2019

Bridging Genomics to Phenomics at Atomic Resolution through Variation Spatial Profiling.

Wang C et al.

Cell Reports, 2018

Accelerated long-term forgetting in presymptomatic autosomal dominant Alzheimer's disease: a cross-sectional study.

Weston PSJ et al.

The Lancet. Neurology, 2018

29413314 (PubMed )
Supplement: mmc1.pdf

Aβ42/Aβ40 Ratios of Presenilin 1 Mutations Correlate with Clinical Onset of Alzheimer's Disease.

Tang N et al.

Journal of Alzheimer's Disease : Jad, 2018

30412504 (PubMed )
Supplement: sj-docx-1-alz-10.3233_jad-180829.docx

Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.

Weston PSJ et al.

Neurology, 2017

29070659 (PubMed )
Supplement: supp_WNL.0000000000004667_Table_e-1.docx

APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases.

Lanoiselée HM et al.

Plos Medicine, 2017

28350801 (PubMed )
Supplement: pmed.1002270.s001.xlsx › PSEN1_mutations

Analysis of 138 pathogenic mutations in presenilin-1 on the in vitro production of Aβ42 and Aβ40 peptides by γ-secretase.

Sun L et al.

Proceedings of the National Academy of Sciences of the United States of America, 2017

Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer's disease: a case series.

Ryan NS et al.

The Lancet. Neurology, 2016

Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.

Weston PS et al.

Neurology, 2016

White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease.

Sánchez-Valle R et al.

Journal of Alzheimer's Disease : Jad, 2016

Mutations, associated with early-onset Alzheimer's disease, discovered in Asian countries.

Bagyinszky E et al.

Clinical Interventions in Aging, 2016

Association between variant amyloid deposits and motor deficits in FAD-associated presenilin-1 mutations: A systematic review.

Zhang S et al.

Neuroscience and Biobehavioral Reviews, 2015

Identification of two novel mutations, PSEN1 E280K and PRNP G127S, in a Malaysian family.

Ch'ng GS et al.

Neuropsychiatric Disease and Treatment, 2015

Multiple Spontaneous Cerebral Microbleeds and Leukoencephalopathy in PSEN1-Associated Familial Alzheimer's Disease: Mirror of Cerebral Amyloid Angiopathy?

Floris G et al.

Journal of Alzheimer's Disease : Jad, 2015

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies.

Ringman JM et al.

Current Neurology and Neuroscience Reports, 2014

Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.

Sepulveda-Falla D et al.

The Journal of Clinical Investigation, 2014

The genetics of Alzheimer's disease.

Bagyinszky E et al.

Clinical Interventions in Aging, 2014

Magnetic resonance imaging evidence for presymptomatic change in thalamus and caudate in familial Alzheimer's disease.

Ryan NS et al.

Brain : a Journal of Neurology, 2013

Variant Alzheimer's disease with spastic paraparesis and supranuclear gaze palsy.

Sinha N et al.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, 2013

Genetic influences on atrophy patterns in familial Alzheimer's disease: a comparison of APP and PSEN1 mutations.

Scahill RI et al.

Journal of Alzheimer's Disease : Jad, 2013

Presenilin-1 mutations in Alzheimer's disease: an update on genotype-phenotype relationships.

Larner AJ

Journal of Alzheimer's Disease : Jad, 2013

BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging.

Glennon EB et al.

Plos One, 2013

Cerebral microbleeds in familial Alzheimer's disease.

Ryan NS et al.

Brain : a Journal of Neurology, 2012

The French series of autosomal dominant early onset Alzheimer's disease cases: mutation spectrum and cerebrospinal fluid biomarkers.

Wallon D et al.

Journal of Alzheimer's Disease : Jad, 2012

Presenilins function in ER calcium leak and Alzheimer's disease pathogenesis.

Supnet C et al.

Cell Calcium, 2011

Presenilins as endoplasmic reticulum calcium leak channels and Alzheimer's disease pathogenesis.

Supnet C et al.

Science China. Life Sciences, 2011

Variant Alzheimer disease with spastic paraparesis: a rare presenilin-1 mutation.

Pettersen JA et al.

The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, 2011

Presenilin-1 mutation Alzheimer's disease: a genetic epilepsy syndrome?

Larner AJ

Epilepsy & Behavior : E&b, 2011

Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers.

Knight WD et al.

Brain : a Journal of Neurology, 2011

gamma-secretases: from cell biology to therapeutic strategies.

Bergmans BA et al.

The Lancet. Neurology, 2010

1–50 of 91 papers
Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."